A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...